To be sure, notallchiefexecutivesattending the meetinghaltedhiring during the downturn. Among them isSuryan.Mohapatra, chairman and CEO of QuestDiagnosticsInc. (DGX).
At issue is the way that Medicare reimburses everyone from the big laboratory companies such as the Laboratory Corp of America (LH:NYSE) and QuestDiagnosticsInc. (DGX:NYSE), to the molecular diagnostic labs inside academic hospitals, and especially smaller firms that make proprietary tests used by doctors to more effectively target treatments to patients with conditions like cancer.
Among the largest underlying components of RYH, in trading today QuestDiagnostics, Inc. ( NYSE: DGX) is up about 0.4%, Medco Health Solutions, Inc. ( NYSE: MHS) is up about 0.1%, and Varian Medical Systems, Inc. ( NYSE: VAR) is higher by about 2.2%.